MTAP and cancer: A different MTAP expression status in metastatic tumor fractions as compared to the molecularly analyzed primary tumor tissue could either prevent response to therapy or—in case of a change from MTAP positivity to MTAP deficiency—lead to a situation where a treatable cancer would not be detected by standard diagnostic procedures.